Digitas Health LifeBrands is a creative agency purpose-built to connect health and wellness brands with peoples’ deep desire to make healthy, confident choices for themselves and for their loved ones. We call this “Helping not Selling.” Creatively-driven, media savvy, and technology-fueled, Digitas Health LifeBrands is the leading digital-at-the-core brand agency for the new era of healthcare marketing. With offices in Philadelphia, New York, San Francisco, London, and Mumbai, it is part of Publicis Healthcare Communications Group, the healthcare division of Publicis Groupe S.A. (Euronext Paris: FR0000130577), the world’s third-largest communications group, second-largest media counsel and buying group, and a leader in digital communications.
AZhelps is a multi-channel customer service innovation bridging the gap between healthcare complexity and healthcare ability. It’s informed by the understanding that life is lived in moments, and the most defining moments involve our health. AZhelps is designed to be there in critical moments to support customers making health decisions.
The partnership is aimed at helping later-stage health startups grow their businesses with marketing and brand strategy advice.
The chief planning officer of North America talks about strategy and how to tell an engaging health story.
It might have seemed slow at the start, but the digital path paid off for this agency
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Novartis aims to bring first oral asthma drug to market in two decades
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- Five things for pharma marketers to know: Tuesday, March 21, 2017
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Publicis Health formalizes new name, promotes 3 execs
- Digital IDs become focus as drugmakers seek to track doctors' behavior online